Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Compass Pathways Plc ADR’s stock clocked out at $4.34, down -6.06% from its previous closing price of $4.62. In other words, the price has decreased by -$6.06 from its previous closing price. On the day, 1.22 million shares were traded.
Ratios:
To gain a deeper understanding of CMPS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.18 and its Current Ratio is at 10.18. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on February 27, 2025, initiated with a Buy rating and assigned the stock a target price of $11.
On July 23, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $23.
On April 01, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $30.Morgan Stanley initiated its Overweight rating on April 01, 2024, with a $30 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 26 ’24 when ATAI Life Sciences N.V. sold 2,660,000 shares for $6.05 per share. The transaction valued at 16,093,000 led to the insider holds 6,905,774 shares of the business.
Stock Price History:
Over the past 52 weeks, CMPS has reached a high of $8.54, while it has fallen to a 52-week low of $2.49. The 50-Day Moving Average of the stock is 25.84%, while the 200-Day Moving Average is calculated to be -10.10%.
Shares Statistics:
A total of 92.85M shares are outstanding, with a floating share count of 84.17M. Insiders hold about 9.34% of the company’s shares, while institutions hold 46.34% stake in the company.
